Boehringer Ingelheim is paying $358 million upfront to claim options on up to six antibody-drug conjugates (ADCs) and T cell ...

As an oncologist with more than 25 years of experience across clinical care, research, drug and device development, and ...

Businesses are finding that AI is a great leveller. Organisations with mature digital infrastructures can use AI to unlock ...

Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy, which ...

Theramex, a London, UK-based specialty pharma company focusing on women's health, is changing hands in a deal reportedly ...

Hard on the heels of a £1 billion investment package by pharma companies in last week's UK Budget, AbbVie has pledged another ...

The BioInnovation Institute (BII) has expanded a network striving to develop treatments for cardiometabolic diseases and ...

Covering the Congress onsite at Messe Berlin, pharmaphorum interviewed experts in their field and reported from the broad oncological programme of presentations itself. Key areas ...

Bayer's pharma unit has reached a "turning point" in its growth trajectory as sales of new medicines rose 6.4% in the third ...

Radiology has traditionally treated its workforce shortage as a speed problem. Imaging volumes continue to rise, specialists remain scarce, and every radiologist is expected to interpret more scans in ...

The Rational Based Drug Design Summit Europe is the dedicated meeting bringing together structural biologists, biophysicists, medicinal chemists, computational chemists, AI drug discovery specialists ...

BrandPRO Biopharma gives teams a practical setting in which to confront them. Participants have to move from discussing strategy to making decisions together. The challenge is to develop the judgement ...